
Pharmstandard
Europe, Moscow City, Russian Federation, Moscow
Description
Pharmstandard is a pharmaceutical company that develops and manufactures modern pharmaceutical products.
Investor Profile
Pharmstandard has backed more than 13 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 62% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Private Equity, Series D rounds (top funding stages).
- Majority of deals are located in United States, Canada, Australia.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series B (38%)
- Private Equity (8%)
- Series D (8%)
- Debt Financing (8%)
- Series C (8%)
- Series E (8%)
- Post Ipo Equity (8%)
- Seed (8%)
- Convertible Note (8%)
Country Focus
- United States (77%)
- Canada (8%)
- Australia (8%)
- Russian Federation (8%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Eyewear
- Genetics
- Medical Device
- Service Industry
- Wellness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.